NSF Carves Out Elite Fellowship From Existing Faculty Awards

WASHINGTON--The National Science Foundation has quietly launched a new, highly selective program of research awards to young faculty. The initiative, to be called the Presidential Science and Engineering Faculty Fellows program, will offer more money than and have different ground rules from those of the existing Presidential Young Investigators (PYI) award, which will now be called simply the NSF Young Investigators Program. And more than a name change may be afoot for the original PYI progra

Written byJeffrey Mervis
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

And more than a name change may be afoot for the original PYI program. There are indications that the more plebeian title is a harbinger of significant revisions in a program that over the past seven years has given five-year, no-strings-attached research grants to more than 1,400 scientists and engineers starting out on their academic careers.

The new faculty fellows program will cost $15 million annually once it is fully implemented over five years. It is expected to be carved out of the existing PYI program, which White House officials decided was too large. The National Science Board approved the new fellows program, set to begin as early as this fall, at its meeting held last month.

"When President Bush found out about the PYI program, he want-ed to be involved much more personally in it than his predecessor," says Mary Clutter, assistant NSF director for the biological and behavioral ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies